ID: ALA4789369

Max Phase: Preclinical

Molecular Formula: C19H28N4O6S2

Molecular Weight: 472.59

Molecule Type: Unknown

Representations

Canonical SMILES:  CC(C)[C@H]1NC(=O)C[C@H]2/C=C/CCSSC[C@@H](NC1=O)C(=O)NCC(=O)NCC(=O)O2

Standard InChI:  InChI=1S/C19H28N4O6S2/c1-11(2)17-19(28)22-13-10-31-30-6-4-3-5-12(7-14(24)23-17)29-16(26)9-20-15(25)8-21-18(13)27/h3,5,11-13,17H,4,6-10H2,1-2H3,(H,20,25)(H,21,27)(H,22,28)(H,23,24)/b5-3+/t12-,13-,17-/m1/s1

Standard InChI Key:  FTXPGTDKAFEPGS-XWDUBYFRSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 472.59

Molecular Weight (Monoisotopic): 472.1450

AlogP: -0.50

#Rotatable Bonds: 1

Polar Surface Area: 142.70

Molecular Species: NEUTRAL

HBA: 8

HBD: 4

#RO5 Violations: 0

HBA (Lipinski): 10

HBD (Lipinski): 4

#RO5 Violations (Lipinski): 0

CX Acidic pKa: 10.42

CX Basic pKa:

CX LogP: -1.29

CX LogD: -1.29

Aromatic Rings: 0

Heavy Atoms: 31

QED Weighted: 0.23

Np Likeness Score: 2.30

References

1. Narita K,Matsuhara K,Itoh J,Akiyama Y,Dan S,Yamori T,Ito A,Yoshida M,Katoh T.  (2016)  Synthesis and biological evaluation of novel FK228 analogues as potential isoform selective HDAC inhibitors.,  121  [PMID:27318982] [10.1016/j.ejmech.2016.05.031]

Source

Source(1):

• Scientific Literature